This line from an article from market herald sums this trial up perfectly. Just imagine if Revascor becomes part of the litany of other treatments that are given to patients with heart disease.
https://themarketherald.com.au/mesoblast-asxmsb-shares-plummet-on-trial-results-2020-12-15/"The data from the trial means Revascor reduces mortality with existing drugs that reduce hospitalisation rates, but does not significantly impact cardiac mortality."
- Forums
- ASX - By Stock
- MSB
- Ann: Mesoblast Phase 3 Chronic Heart Failure Results
Ann: Mesoblast Phase 3 Chronic Heart Failure Results, page-326
-
- There are more pages in this discussion • 697 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
98.5¢ |
Change
0.015(1.55%) |
Mkt cap ! $1.107B |
Open | High | Low | Value | Volume |
96.0¢ | 99.0¢ | 95.5¢ | $2.545M | 2.608M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 82692 | 98.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
98.5¢ | 55160 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 82692 | 0.980 |
38 | 264380 | 0.975 |
28 | 593408 | 0.970 |
10 | 89517 | 0.965 |
12 | 226526 | 0.960 |
Price($) | Vol. | No. |
---|---|---|
0.985 | 56650 | 11 |
0.990 | 128661 | 14 |
0.995 | 77617 | 11 |
1.000 | 101359 | 12 |
1.010 | 46937 | 6 |
Last trade - 12.14pm 27/06/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |